Skip to main content
logo
MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.730
-0.020 (-1.14%)
At close: Feb 4, 2026, 4:00 PM EST
1.700
-0.030 (-1.73%)
After-hours: Feb 4, 2026, 4:25 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Collaborative and Other Agreements
28.99M
Collaborative and Other Agreements Growth
-75.70%
Monoclonal Antibody-based Therapeutics
17.94M
Monoclonal Antibody-based Therapeutics Growth
7.25%
Contract Manufacturing
9.83M
Contract Manufacturing Growth
-29.70%
Government Agreements
1.56M
Government Agreements Growth
-19.08%
Royalty
431.00K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
58.75M
United States Growth
-61.33%